Table 2 Prediction of pathological complete remission without Ki67, using multiple linear regression analysis (final model)
From: Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Characteristic | OR | 95% CI | P |
|---|---|---|---|
pT | Â | Â | Â |
   1 | 1 | - | - |
   2-4 | 0.39 | 0.21-0.73 | < 0.01 |
Grading | Â | Â | Â |
   1-2 | 1 | - | - |
   3 | 2.95 | 1.67-5.24 | < 0.001 |
Estrogen receptor status | |||
   Negative | 1 | - | - |
   Positive | 0.28 | 0.13-0.57 | < 0.001 |
Progesterone receptor status | |||
   Negative | 1 | - | - |
   Positive | 0.42 | 0.19-0.92 | 0.03 |
HER2/neu receptor status | |||
   Negative | 1 | - | - |
   Positive | 2.42 | 1.36-4.32 | < 0.01 |